Abdool Karim

Salim S. Abdool Karim, MBChB, PhD

Lab Info:

Principal Investigator: Salim S. Abdool Karim, MBChB, PhD

Office/Location: UKZN

Phone: +27-31-260-4548

Email: karims1@ukzn.ac.za

Category: Associate Members

Salim S. Abdool Karim, MBChB, PhD, is Pro Vice-Chancellor (Research), University of KwaZulu-Natal and Director of the Centre for the AIDS Program of Research in South Africa (CAPRISA). He is also Professor of Clinical Epidemiology at Columbia University and Adjunct Professor of Medicine at Cornell University, New York.


He was co-Principal Investigator of the CAPRISA 004 trial of tenofovir gel which provided proof of concept that the antiretroviral drug, tenofovir, can prevent sexually transmitted HIV infection in women. He was involved in the development, as patent co-inventor, of clade C HIV vaccines and subsequently led the first HIV vaccine trial in South Africa. His clinical research on TB-HIV treatment has impacted on and continues to shape the clinical management of co-infected patients.


He is a Member of the WHO Expert Advisory Panel on Sexually Transmitted Infections and HIV, Member of the Scientific Advisory Board of the US President’s Emergency Plan for AIDS Relief (PEPfAR), Member of the Institute of Medicine’s Committee on “Envisioning a strategy to prepare for the long-term burden of HIV/AIDS” and Member of the Strategic Advisory Board of the Global HIV Vaccine Enterprise.